The NICHD conducts and supports a variety of clinical research projects related to hypoparathyroidism. Select a link below to learn more about these projects.
Featured NICHD Clinical Trials on Hypoparathyroidism
Treatment of Hypoparathyroidism with Synthetic PTH For more than two decades, researchers conducting this study have been providing and evaluating a synthetic parathyroid hormone, known as PTH 1-34, for use in severe cases of hypoparathyroidism. This study examines the long-term effects of PTH therapy on calcium metabolism, bone, and renal function.
Pump versus Injection Synthetic PTH delivery. This study evaluates the safety and effectiveness of pump-delivered PTH compared with twice-daily injections. The researchers hypothesize that the pump method will provide smoother metabolic control of serum mineral levels and normalization of urine mineral excretion.
NICHD Clinical Trials
All NICHD Clinical Trials on hypoparathyroidism
ClinicalTrials.gov Search Results
Information on current NIH-sponsored clinical trials on hypoparathyroidism is available at the link below or by calling 1-800-411-1222.
All ClinicalTrials.gov Trials on hypoparathyroidism